Journal
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
Volume 12, Issue 4, Pages 184-188Publisher
SAGE PUBLICATIONS INC
DOI: 10.2310/7750.2008.07036
Keywords
-
Categories
Ask authors/readers for more resources
Background: Infliximab, a tumor necrosis factor a antagonist, has recently been shown to be successful for the short-term treatment of generalized pustular psoriasis (GPP) in multiple case reports. Objective: The goal of this case series was to assess the efficacy of the longer-term management of GPP with infliximab. Methods: Three patients with severe GPP were followed to assess the efficacy of long-term treatment with infliximab. Results: Infliximab therapy was more efficacious with infusion every 6 to 8 weeks in combination with methotrexate. Conclusion: Infliximab may be efficacious for some patients for the long-term management of GPP. Maintaining a strict infliximab infusion schedule and concomitant methotrexate therapy may decrease infusion reactions and increase efficacy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available